Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Saudi Arabia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| No longer available | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| Pfizer | 2 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| Hoffmann-La Roche | 1 |
| Janssen Research & Development, LLC | 1 |
| Mirati Therapeutics Inc. | 1 |
| NRG Oncology | 1 |
| National Guard Health Affairs | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 14 |
| Lung Neoplasms | 4 |
| Small Cell Lung Carcinoma | 2 |
| Breast Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma | 1 |
| Multiple Myeloma | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms, Plasma Cell | 1 |
| Prostatic Neoplasms | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.